All posts by: Michael Zand

About Michael Zand

CRISPR Therapeutics Announces Proposed Public Offering of Common Shares – GlobeNewswire (press release)

Continue reading

2018-01-03 NEWS

The Ledger Gazette

CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
GlobeNewswire (press release)
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced that it is
Crispr Therapeutics’ (CRSP) “Hold” Rating Reaffirmed at CannThe Ledger Gazette
Looking for stock with Analysts Rating? CRISPR Therapeutics AG (CRSP)Wall Street Morning
Unusual Activity Sighted in CRISPR Therapeutics AG (:CRSP) SharesThe Herald

all 7 news articles »

Continue reading

2018-01-03 NEWS

Technology Networks

First Step Toward CRISPR Cure for Lou Gehrig’s Disease
Technology Networks
First Step Toward CRISPR Cure for Lou Gehrig’s Disease. News Jan 03, 2018 | Original story from UC Berkeley. First Step Toward CRISPR Cure for Lou Gehrig’s Disease. A cross-section of mouse spinal cord tissue showing cells in which the CRISPR-Cas9 gene